John A. Goodfellow
Papers
1
Total Citations
125
H-Index
1
About
John A. Goodfellow is a leading clinical researcher in neuromuscular medicine, with a primary focus on myasthenia gravis (MG) and autoimmune neurological disorders. His most cited work, “A Practical Approach to Managing Patients With Myasthenia Gravis—Opinions and a Review of the Literature” (2020, 125 citations), provides a comprehensive framework for achieving prompt symptom control and remission in MG patients. Goodfellow’s contributions emphasize the strategic use of acetylcholinesterase inhibitors like pyridostigmine, while also integrating modern immunosuppressive and biologic therapies to optimize long-term outcomes. His research has shaped clinical guidelines, offering practical, evidence-based algorithms that bridge the gap between specialist care and general neurology practice. With over 125 citations on this single paper, his influence is evident in how clinicians worldwide approach MG management. Goodfellow is also recognized for his work on thymoma-associated MG and the role of complement inhibitors in refractory cases. His clear, patient-centered writing and collaborative reviews have made him a trusted voice in the field, helping to standardize care and improve quality of life for individuals living with this chronic, often debilitating condition.
Research Focus
Key Achievements
Top Papers
- 1